The A1R-CT peptide the scientists developed, which can be administered through a nasal spray, holds promise for tamping down the uncontrolled electrical activity that is common after traumatic ...

The FDA has approved Pfizer's nasal spray to treat migraines in adults. The medication, called Zavzpret, is expected to be available via a doctor's prescription in July 2023.

Gulf Breeze, FL, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Limitless Biotech, a leading innovator in the field of biohacking and cognitive enhancement, ...

Credit: Pfizer. Zavzpret (zavegepant) nasal spray is a calcitonin gene-related peptide (CGRP) receptor antagonist. The Food and Drug Administration (FDA) has approved Zavzpret ™ (zavegepant ...

A new nasal spray from Pfizer called Zavegepant promises to relieve migraine pain symptoms within 30 minutes. ... Gepants work by blocking calcitonin gene-related peptide receptors, ...

On Mar. 10, the U.S. Food and Drug Administration (FDA) approved a new treatment for migraines given as a nasal spray, according to the drug’s maker, Pfizer. Zavegepant (brand name: Zavzpret ...

A new nasal spray medication called zavegepant, ... “So it works by targeting a very specific chemical in the brain called ‘calcitonin gene-related peptide,’ or CGRP for short,” she explained.

Zavegepant also was superior to placebo at providing freedom from pain at two hours after a dose. It is the first calcitonin gene-related peptide receptor antagonist nasal spray for migraines, the ...

As a nasal spray with rapid drug absorption, Zavzpret offers an alternative treatment option for people who need pain relief or cannot take oral medications due to nausea or vomiting, so they can ...

The first needle-free emergency treatment for anaphylaxis – in the form of a nasal spray – will now be available in the UK.